News/ News/ Oncology/ Top stories AZ’s Tagrisso wins new NSCLC first-line approval in Europe Dominic Tyer AstraZeneca, EGFT, lung cancer, NSCLC, Tagrisso 0 Comment AstraZeneca has widened the licence for its cancer drug Tagrisso (osimertinib) in Europe after regulators gave it the Share X AZ’s Tagrisso wins new NSCLC first-line approval in Europe https://pharmaphorum.com/news/az-tagrisso-nsclc-egfr-europe/
